Kusajili – Clinical trials directory

Your research

Source: isrctn - Country: Norway,New Zealand,Hungary,Sweden,Belgium,United Kingdom,Netherlands,Slovenia,Australia,Poland,Denmark,Switzerland - Promoter: European Organisation for Research and Treatment of Cancer (EORTC) (Belgium)

European Organisation for Research and Treatment of Cancer (EORTC) (Belgium) Update Il y a 5 ans

Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma (NHL): a phase III randomised clinical trial (Intergroup Collaborative Study) Not provided at time of registration

Country Australia, Belgium, Canada, Denmark, Egypt, France, Hungary, Italy, Netherlands, New Zealand, Norway, Poland, Slovakia, Slovenia, South Africa, Sweden, Switzerland, United Kingdom,
organs None
Specialty None

Closed trial

More information

1